Home Industry News

Industry News

News from pharmaceutical companies and other related healthcare organizations

Two clinical trials for acromegaly patients: see if you are eligible.

Camurus AB, a pharmaceutical company based in Lund, Sweeden, is currently recruiting volunteers for two clinical trials on the long-term safety and efficacy of...

On drug and therapy developments for rare diseases

From the desk of Jorge D Faccinetti, Chairman and chief editor - On April 28, the leading orphan drug industry, government and regulatory authorities,...

The Road to MYCAPSSA: A Conversation with Dr. Bill Ludlam

We recently had a chance to sit down with Chiasma Inc.’s Senior VP of Clinical Development & Medical Affairs, Dr. Bill Ludlam, to discuss...

Hello, Pills!

With the recent approval and commercial launch of MYCAPSSA®, Chiasma delivers the first and only oral somatostatin analog to treat acromegaly. The research showed...

Crinetics new drug candidate for acromegaly Paltusotine awarded Orphan Drug Designation

From a Crinetics Pharmaceutical press release:  Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel...

More information on Recordati’s new Cushing’s drug Isturisa

In a recent press release, Recordati Rare Diseases announced the results from a Phase III study of Isturisa® (Osilodrostat) published in Lancet Diabetes and...

More news on Isturisa for Cushing’s

In a recent press release, Recordati Rare Diseases Inc., a biopharmaceutical company committed to developing therapies for rare disease communities of the United States,...

From Endocrine Web: New Oral Acromegaly Treatment Has No Needles Required

From the editors' desk - A recent Endocrine Web article by Kimberly B. Bjugstad Ph.D. highlights a new oral octreotide drug for Acromegaly.  The drug currently...

A new drug for Cushing’s: Learn more

In this podcast, Dr. Lewis Blevins discusses a new drug for Cushing's disease recently approved in the US.  

Exciting news for acromegaly and NET’s from Crinetics Pharmaceuticals!

In a press release today, San Diego, California based Crinetics Pharmaceuticals reports positive results from their Phase Two trial of PALTUSOTINE (the former CRN00808)....

NEWS YOU CAN USE

Articles you may like